Llewelyn Rao, MD
Retina Specialist · Beachwood, OHNPI 1518165448
Payments from drug & device makers
Across 453 payments — averaging $1585.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apellis Pharmaceuticals, Inc.$488K
- Regeneron$173K
- US Retina LLC$25K
- Carl Zeiss Meditec, Inc.$18K
- Genentech USA, Inc.$5K
- Alimera Sciences, Inc.$3K
- plus $6K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 110 | $487,816 |
| Regeneron | 69 | $172,806 |
| US Retina LLC | 12 | $24,977 |
| Carl Zeiss Meditec, Inc. | 4 | $18,028 |
| Genentech USA, Inc. | 38 | $5,455 |
| Alimera Sciences, Inc. | 33 | $3,318 |
| Regeneron Healthcare Solutions, Inc. | 72 | $1,834 |
| AbbVie(2 entities) | 40 | $1,225 |
| Dutch Ophthalmic, USA | 9 | $990 |
| Astellas Pharma US Inc | 11 | $329 |
| Novartis | 14 | $298 |
| Coherus Oncology, Inc. | 5 | $236 |
| Notal Vision, Inc. | 1 | $159 |
| Bausch & Lomb Americas Inc. | 3 | $136 |
| ANI Pharmaceuticals, Inc. | 6 | $113 |
| Eyepoint US, Inc. | 6 | $101 |
| Genentech, Inc. | 1 | $93 |
| Harrow Eye, LLC | 3 | $89 |
| Biogen | 3 | $67 |
| Rayner Intraocular Lenses Limited | 3 | $54 |
| Mallinckrodt Hospital Products Inc. | 2 | $39 |
| Kala Pharmaceuticals, Inc. | 2 | $27 |
| Ivantis, Inc | 1 | $25 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $24 |
| Ocular Therapeutix, Inc. | 1 | $18 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $18 |
| Alcon | 1 | $17 |
| Omeros Corporation | 1 | $16 |
How this compares
$718,307 in reported general payments places this provider in the 90th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Beachwood
- Joseph ConeyBeachwood$2.1M
- David MillerBeachwood$299K
- Michael NovakBeachwood$71K
- Scott PendergastBeachwood$66K
- Jerome SchartmanBeachwood$49K
- Sean PlattBeachwood$42K
- Lediana GoduniBeachwood$9K
- Shawn LewisBeachwood$7K
- David ShiehBeachwood$3K
- Hernando ZegarraBeachwood$478
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.